Sign In

Login

Password

Forgot Password ? Sign Up

Trimetrexato (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Trimetrexato" in Italian language version.

refsWebsite
Global rank Italian rank
13nih.gov
4th place
9th place
1oadoi.org
799th place
22nd place
1doi.org
2nd place
7th place

doi.org

dx.doi.org

nih.gov

ncbi.nlm.nih.gov

  • JR Bertino, Folate antagonists: toward improving the therapeutic index and development of new analogs, in J Clin Pharmacol., vol. 30, n. 4, Apr 1990, pp. 291-5, PMID 2140369.
  • JR. Bertino, WL. Sawicki; BA. Moroson; AR. Cashmore; EF. Elslager, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (tmq), a potent non-classical folate antagonist inhibitor--I effect on dihydrofolate reductase and growth of rodent tumors in vitro and in vivo., in Biochem Pharmacol, vol. 28, n. 12, Giu 1979, pp. 1983-7, PMID 454469.
  • RC. Jackson, DW. Fry; TJ. Boritzki; JA. Besserer; WR. Leopold; BJ. Sloan; EF. Elslager, Biochemical pharmacology of the lipophilic antifolate, trimetrexate., in Adv Enzyme Regul, vol. 22, 1984, pp. 187-206, PMID 6236675.
  • EC. Weir, AR. Cashmore; RN. Dreyer; ML. Graham; N. Hsiao; BA. Moroson; WL. Sawicki; JR. Bertino, Pharmacology and toxicity of a potent nonclassical 2,4-diamino quinazoline folate antagonist, trimetrexate, in normal dogs., in Cancer Res, vol. 42, n. 5, Mag 1982, pp. 1696-702, PMID 6461409.
  • JL Marshall, RJ DeLap, Clinical pharmacokinetics and pharmacology of trimetrexate, in Clin Pharmacokinet., vol. 26, n. 3, Mar 1994, pp. 190-200, PMID 8194282.
  • DG. Haller, Trimetrexate: experience with solid tumors., in Semin Oncol., vol. 24, (5 Suppl 18), Ott 1997, pp. S18-71-S18-76, PMID 9420024.
  • AA Garcia, L Leichman; J Baranda; L Pandit; HJ Lenz; CG Leichman, Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer., in Int J Gastrointest Cancer, vol. 34, n. 2-3, 2003, pp. 79-86, PMID 15361639.
  • H. Diddens, D. Niethammer; RC. Jackson, Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate., in Cancer Res, vol. 43, n. 11, Nov 1983, pp. 5286-92, PMID 6225514.
  • A. Pappo, R. Dubowy; Y. Ravindranath; C. Alvarado; S. Rao; VM. Whitehead; R. Vega; B. Kamen; T. Vietti, Phase II trial of trimetrexate in the treatment of recurrent childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study., in J Natl Cancer Inst, vol. 82, n. 20, Ott 1990, pp. 1641-2, PMID 2145440.
  • CJ. Allegra, BA. Chabner; CU. Tuazon; D. Ogata-Arakaki; B. Baird; JC. Drake; JT. Simmons; EE. Lack; JH. Shelhamer; F. Balis, Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome., in N Engl J Med, vol. 317, n. 16, Ott 1987, pp. 978-85, DOI:10.1056/NEJM198710153171602, PMID 2958710.
  • FR. Sattler, CJ. Allegra; TD. Verdegem; B. Akil; CU. Tuazon; C. Hughlett; D. Ogata-Arakaki; J. Feinberg; J. Shelhamer; HC. Lane, Trimetrexate-leucovorin dosage evaluation study for treatment of Pneumocystis carinii pneumonia., in J Infect Dis, vol. 161, n. 1, Gen 1990, pp. 91-6, PMID 2136905.
  • GW. Amsden, SF. Kowalsky; GD. Morse, Trimetrexate for Pneumocystis carinii pneumonia in patients with AIDS., in Ann Pharmacother, vol. 26, n. 2, Feb 1992, pp. 218-26, PMID 1532518.
  • B. Fulton, AJ. Wagstaff; D. McTavish, Trimetrexate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of Pneumocystis carinii pneumonia., in Drugs, vol. 49, n. 4, Apr 1995, pp. 563-76, PMID 7789290.

oadoi.org